XML 59 R8.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statements of Cash Flows (USD $)
In Thousands, unless otherwise specified
 3 Months Ended 6 Months Ended 9 Months Ended
Sep. 30, 2014
Jul. 09, 2014
Predecessor
Sep. 30, 2013
Predecessor
Sep. 30, 2013
Predecessor
2010 Baltic Trading Credit Facility
Sep. 30, 2013
Predecessor
Baltic Trading Term Loan Facility One [Member]
Cash flows from operating activities:          
Net (loss) income $ (22,562) $ 784,557 $ (137,866)    
Adjustments to reconcile net (loss) income to net cash used in operating activities:          
Non-cash reorganization items and fresh start accounting adjustments, net   917,399      
Depreciation and amortization 17,356 75,952 104,322    
Amortization of deferred financing costs 384 4,461 6,862    
Amortization of time charters acquired 434 (68) (283)    
Amortization of discount on Convertible Senior Notes   1,592 3,653    
Interest expense related to the de-designation of the interest rate swap   1,048      
Unrealized loss on derivative instruments     3    
Amortization of nonvested stock compensation expense 7,872 4,352 3,470    
Change in assets and liabilities:          
(Increase) decrease in due from charterers (2,400) 1,047 (3,066)    
Decrease (increase) in prepaid expenses and other current assets 5,519 (11,735) (244)    
(Decrease) increase in accounts payable and accrued expenses (27,998) 32,534 146    
(Decrease) increase in deferred revenue (104) (600) 98    
Increase in lease obligations 186 195 152    
Deferred drydock costs incurred (2,977) (9,253) (1,873)    
Net cash used in operating activities (24,290) (33,317) (24,626)    
Cash flows from investing activities:          
Purchase of vessels, including deposits (918) (29,995) (41,097)    
Purchase of other fixed assets (30) (415) (427)    
Changes in deposits of restricted cash 125 (125)      
Net cash used in investing activities (823) (30,535) (41,524)    
Cash flows from financing activities:          
Proceeds from Term Loan Facility       1,000 22,000
Payment of dividend by subsidiary (512) (2,046) (584)    
Cash settlement of non-accredited Note holders (375)        
Proceeds from Rights Offering   100,000      
Proceeds from issuance of common stock by subsidiary     81,700    
Payment of common stock issuance costs by subsidiary   (111) (379)    
Payment of deferred financing costs (471) (4,515) (695)    
Net cash (used in) provided by financing activities (4,344) 77,207 103,042    
Net (decrease) increase in cash and cash equivalents (29,457) 13,355 36,892    
Cash and cash equivalents at beginning of period 136,077 122,722 72,600    
Cash and cash equivalents at end of period $ 106,620 $ 136,077 $ 109,492